Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2007
08/23/2007US20070196489 Taste masked pharmaceutical particles
08/23/2007US20070196488 Oral matrix formulations comprising licarbazepine
08/23/2007US20070196487 Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
08/23/2007US20070196486 Stable oral formulation containing benzimidazole derivative
08/23/2007US20070196485 Stable benzimidazole formulation
08/23/2007US20070196484 Poorly water-soluble drug-containing solid formulation
08/23/2007US20070196483 Taste-Masked Drugs in Rupturing Multiparticulates
08/23/2007US20070196482 a sustained release excipient ( gelling agent waxes, cellulose ether, acrylic polymer, oil, protein derived material, shellac) incorporated into a matrix along with the drug (e.g., torsemide), or applied as a controlled release coating; treatment of edema, congestive heart failure associated with edema
08/23/2007US20070196481 Sustained-release tablet composition
08/23/2007US20070196480 Sustained release formulation for oral administration of hmg-coa reductase inhibitor and method for the preparation thereof
08/23/2007US20070196479 Method For The Timed Dosage Of Medicaments
08/23/2007US20070196478 Antiviral compositions
08/23/2007US20070196477 Rapidly dissolving tablets comprising low surface area calcium phosphates
08/23/2007US20070196476 Rapidly dissolving tablets comprising low surface area titanium dioxide
08/23/2007US20070196475 Rapidly disintegrating low friability tablets comprising silica materials
08/23/2007US20070196474 Rapidly disintegrating low friability tablets comprising calcium carbonate
08/23/2007US20070196473 Pharmaceutical compositions containing flibanserin
08/23/2007US20070196472 Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions
08/23/2007US20070196470 comprising L-Arginine, Xanthinol Nicotinate, and yohimbine; bioavailability; Croscarmellose and/or Crospovidone as agents of disintegration
08/23/2007US20070196469 Magnesium microtablets with sustained release
08/23/2007US20070196468 Simethicone solid oral dosage form
08/23/2007US20070196467 Indium supplement compositions and methods therefor
08/23/2007US20070196466 Pharmaceutical formulations containing flavouring substances with improved pharmaceutical properties
08/23/2007US20070196465 Treatment with dihydropyridine calcium channel blockers and omega-3 fatty acids and a combination product thereof
08/23/2007US20070196464 Bioavailability; absorption; using fatty acid, or salt thereof, or fatty ester
08/23/2007US20070196463 Enteric Soft Gelatin Capsule Containing Esomerpazole And Method Of Preparation
08/23/2007US20070196462 Composition and method for neuromuscular blockade
08/23/2007US20070196461 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
08/23/2007US20070196460 External preparation for treating skin or mucosal injury caused by viral infection
08/23/2007US20070196455 Crosslinkable pressure-sensitive adhesive for skin
08/23/2007US20070196453 Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
08/23/2007US20070196452 Flux-enabling compositions and methods for dermal delivery of drugs
08/23/2007US20070196451 Extendable rolled delivery system
08/23/2007US20070196450 Delivery system for topical medications
08/23/2007US20070196447 such as nystatin and flavor modifier; chewable dosages
08/23/2007US20070196446 Conjugated fatty acid esters
08/23/2007US20070196444 Pantoprazole multiparticulate formulations
08/23/2007US20070196443 Spherical core with enteric overcoating; antiulcer agents
08/23/2007US20070196441 Process for Making Orally Consumable Dosage Forms
08/23/2007US20070196433 Methods and devices for the sustained release of multiple drugs
08/23/2007US20070196427 Method for preparing adjustably bioresorbable sol-gel derived sio2
08/23/2007US20070196425 Thermosensitive and biodegradable microgel and a method for the preparation thereof
08/23/2007US20070196419 Composite Materials Based On Polysilicic Acid And Method For The Production Thereof
08/23/2007US20070196417 Therapeutic polyanhydride compounds for drug delivery
08/23/2007US20070196410 Slow-Release Microcapsule Composition for Safe Delivery of Agriculturally Active Material
08/23/2007US20070196401 Nano-Fiber Compound Solutions, Emulsions And Gels, Production Method Thereof, Nano-Fiber Synthetic Papers, And Production Method Thereof
08/23/2007US20070196399 Enteric-coated preparation covered with enteric coating material for site-specific delivery of drug to site within the small intestine
08/23/2007US20070196397 Method And Device For Producing Micro-Droplets
08/23/2007US20070196396 Controlled release pharmaceutical compositions with improved bioavailability
08/23/2007US20070196391 Mucosal boosting following parenteral priming
08/23/2007US20070196342 Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects
08/23/2007US20070196333 Composition comprising mixtures of IFN-alpha subtypes
08/23/2007US20070196286 Aerosol composition comprising formoterol
08/23/2007US20070196285 Novel combination of anticholinergics - B2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases
08/23/2007US20070196284 Micelles associated to outer surface of liposome envelope by electrostatic interaction; active compound incorporated into the micelles linking a large amount of active compound to a single liposome carrier; bioavailability; image-enhanced contrast agents for imaging (MRI); tissue-targeted therapy
08/23/2007US20070196283 Composition for transfection of DNA into the liver
08/23/2007DE102006006532A1 Pharmazeutische Zubereitung Pharmaceutical composition
08/23/2007DE102006006510A1 Lokales Wirkstofffreisetzungssystem und ein Verfahren zu seiner Herstellung Local drug release system and a process for its preparation
08/23/2007DE102006006413A1 UV-Filter-Kapsel UV filter capsule
08/23/2007CA2838399A1 Formulations for a tight junction effector
08/23/2007CA2649265A1 Microparticulate pharmaceutical forms resistant to immediate release of the active principle in the presence of alcohol
08/23/2007CA2643327A1 Press-fit rapid release medicament and method and apparatus of manufacturing
08/23/2007CA2642785A1 Passive time released solute treatment
08/23/2007CA2642641A1 Stable corticosteroid mixtures
08/23/2007CA2642579A1 Sterilization of corticosteroids with reduced mass loss
08/23/2007CA2642414A1 Rapid release irbesartan-containing pharmaceutical composition
08/23/2007CA2642338A1 Adhesive preparation comprising sufentanil and methods of using the same
08/23/2007CA2642255A1 Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture
08/23/2007CA2642042A1 Radio frequency induced drug elution
08/23/2007CA2641950A1 All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
08/23/2007CA2641906A1 Applications of microencapsulated essential oils
08/23/2007CA2641616A1 Pharmaceutical formulations
08/23/2007CA2641605A1 Pharmaceutical formulations
08/23/2007CA2641604A1 Pharmaceutical formulations
08/23/2007CA2640560A1 Joining and/or sealing tissues through photo-activated cross-linking of matrix proteins
08/23/2007CA2640243A1 Disintegrable oral films
08/23/2007CA2633588A1 Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same
08/23/2007CA2556305A1 Rapidly dissolving solid oral dosage form for delivery of composition for increasing nitric oxide activity
08/22/2007EP1820516A2 Novel albumin-free factor VIII formulations
08/22/2007EP1820507A1 A pharmaceutical composition for the medical treatment of the benign prostatic hyperplasia, its preparation method and its therapeutical application
08/22/2007EP1820506A1 Dipyridamole extended-release formulations and process for preparing same
08/22/2007EP1820498A2 Enteric-coated preparation for site-specific delivery of drug to site within the small intestine
08/22/2007EP1820497A2 Effervescent bisphosphonate formulation
08/22/2007EP1820496A2 Implant material
08/22/2007EP1820495A2 Microspheres for active embolization
08/22/2007EP1820494A2 Microspheres of estradiol and cholesterol
08/22/2007EP1820493A2 Aerosols for sinunasal drug delivery
08/22/2007EP1819362A2 Topical nepafenac formulations
08/22/2007EP1819352A1 Pharmaceutical compositions from carapa guianensis
08/22/2007EP1819324A1 Solid particles from controlled destabilisation of microemulsions
08/22/2007EP1819323A2 Pharmaceutical composition containing an anti-nucleating agent
08/22/2007EP1819322A2 Formulations of substituted benzoxazoles
08/22/2007EP1819321A2 Formulations of substituted benzoxazoles
08/22/2007EP1819320A1 Orally dispersible pharmaceutical composition and process for the preparation thereof
08/22/2007EP1819319A1 Pharmaceutical compositions of amorphous atorvastatin and process for preparing same
08/22/2007EP1819318A1 Dried forms of aqueous solubilized bile acid dosage formulation
08/22/2007EP1819297A2 Uv cured gel and method of making
08/22/2007EP1819289A1 Controlled ocular lens regeneration
08/22/2007EP1691745A4 Methods and compositions for treating skin wounds
08/22/2007EP1684851B1 Methods for preparing polymeric buffer formulations for electrotransport applications